Wikidata

(Q34613164)

English

VMP (Bortezomib, Melphalan, and Prednisone) is active and well tolerated in newly diagnosed patients with multiple myeloma with moderately impaired renal function, and results in reversal of renal impairment: cohort analysis of the phase III VISTA s

scientific article

In more languages

Statements

title
VMP (Bortezomib, Melphalan, and Prednisone) is active and well tolerated in newly diagnosed patients with multiple myeloma with moderately impaired renal function, and results in reversal of renal impairment: cohort analysis of the phase III VISTA study (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19858394
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858394%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 February 2020
author

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q34613164&oldid=2081745851"